After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy Wojcicki has started out hot with an opening bid nearly $50 million higher than the previous auction’s winner. Last month, Regeneron Pharmaceuticals purchased the bankrupt 23andMe for $256 million, beating out Wojcicki’s […]